News and Trends 10 Feb 2023
Janssen reports positive topline phase 2 HDFN results
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the proof-of-concept phase 2 open-label UNITY…
Janssen
- Latest Posts
News and Trends 12 Jan 2023
Beyond Biotech podcast 29: Janssen, Knowledge Gate
This week, our guests are Viktoriya Vasilenko, Knowledge Gate co-founder and CEO; and Avery Ince, vice president, medical affairs, cardiovascular…
News and Trends 3 Jan 2023
Janssen looks for talquetamab marketing approval
The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a marketing authorisation application (MAA) to the European Medicines Agency…
News and Trends 4 Oct 2022
ASPIRE set up to collaborate on amyloidosis
A new group of biotech and pharma companies has been assembled by the Amyloidosis Research Consortium (ARC). ASPIRE (amyloidosis stakeholder…
ADVERTISEMENT
News and Trends 5 Sep 2022
Synairgen to collaborate on study of patients hospitalized due to respiratory viruses
Synairgen plc is to collaborate on a University of Southampton study on acute respiratory viral infection and recovery in hospital…
News and Trends 25 Aug 2022
Hope for children with chronic graft versus host disease as Johnson & Johnson drug approved
A treatment for chronic graft versus host disease in children aged one year and older has been approved by the…
More News! 18 Aug 2022
Collaboration to advance investigational tuberculosis drug treatments
A collaboration called The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) was announced yesterday (August 17). The joint development…
News and Trends 7 Jun 2022
Yumanity selling neurology assets and merging with Kineta
U.S. biopharma company Yumanity Therapeutics, Inc. is selling off its lead clinical-stage neurodegenerative product candidate YTX-7739 to Janssen Pharmaceutica NV,…
News and Trends 15 Feb 2022
Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials
Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to healthcare systems worldwide. Numerous treatments…
News and Trends 20 Dec 2019
Update: First Ever Ebola Vaccine Gets US and EU Approval
Update (20/12/2019): After getting conditional approval in Europe in November, Merck has received FDA approval for its Ebola vaccine, the…
News and Trends 31 Oct 2019
European Project Launches to Tailor Autoimmune Disease Treatments
Public and private organizations across Europe will pool their resources in an €80M project to discover biomarkers that can predict…
News and Trends 22 Aug 2019
Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III
An experimental HIV therapy being developed by GSK spinoff ViiV Healthcare in partnership with Janssen has proven it is as…
News and Trends 11 Jun 2019
Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster
Janssen and the Danish biotech Genmab will collaborate to develop a new antibody that could outperform their blockbuster cancer drug…
News and Trends 28 Jan 2019
Update: US District Court Rules Against MorphoSys’ Cancer Immunotherapy Patents
Update (01/02/2019): MorphoSys has agreed to end its long-running legal battle with Genmab and Janssen, after the US District Court of…
News and Trends 25 Jan 2019
Swiss-Italian Biotech Bags Antibody Deals with Three Big Pharma
The Swiss-Italian company Philogen has announced three different partnerships with Novartis, Celgene, and Janssen to develop new forms of immunotherapy…
News and Trends 13 Dec 2018
Janssen Recruits Microbiome Company to Fight Inflammatory Bowel Disease
The Israeli biotech BiomX has teamed up with Janssen to use its microbiome technology in the treatment of inflammatory bowel…
ADVERTISEMENT
News and Trends 1 Nov 2018
Llama Antibodies Could Be the Key to Universal Flu Prevention
Researchers have developed a new approach to prevent the flu that can protect against all seasonal strains of the virus.…
News and Trends 6 Jul 2018
A New HIV Vaccine Could Protect Patients Against Multiple Viral Strains
A new HIV vaccine is moving into a Phase IIb trial and could potentially protect patients against multiple HIV strains…
News and Trends 8 Feb 2018
Janssen Biotech Offers up to $1Bn to Irish Biotech for a Bowel Inflammation Drug
Janssen Biotech and Theravance Biopharma will develop together a drug to treat bowel inflammation diseases like ulcerative colitis and Crohn's…
News and Trends 4 Dec 2017
Swiss Biotech Brings in Reinforcements to See Hypertension Drug Through Phase III
Idorsia will collaborate with Janssen on the development of its hypertension drug, aprocitentan, which could help to prevent future heart…
